Psoriasis Clinical Trials in Los Angeles

Showing 181-200 of 205 trials

Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT01483924

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of 12 weeks of treatment with Apo805K1 in subjects with moderate to severe chronic plaque psoriasis.

Plaque Psoriasis

ApoPharma60 participantsStarted Nov 2011

Los Angeles, California, United States • Los Angeles, California, United States • Dallas, Texas, United States +4 more locations

COMPLETED< 1 mile

An Exploratory Genetic Study in Participants With Psoriasis

NCT02155192

The purpose of this study is to evaluate the association between genetic factors and response to treatment (guselkumab, ustekinumab, adalimumab, or etanercept) and psoriasis (scaly skin rash).

Psoriasis

Janssen Research & Development, LLC712 participantsStarted Mar 2014

Bakersfield, California, United States • Los Angeles, California, United States • Ocala, Florida, United States +16 more locations

COMPLETEDPhase 3< 1 mile

A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents

NCT01077362

The purpose of this study is to evaluate the efficacy (improvement of signs and symptoms) and safety of ustekinumab in patients with psoriatic arthritis.

Arthritis, Psoriatic

Janssen Research & Development, LLC312 participantsStarted Mar 2010

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Los Angeles, California, United States +77 more locations

Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

An Exploratory Genetic Study in Participants With Psoriasis

A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents

Psoriasis Trials in Other Cities

A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Open Label Continuation Study in Moderate to Severe Psoriasis

A Study for Adults With Plaque Psoriasis

A Study to Assess the Pharmacokinetics, Immunogenicity and Safety of Escalating Doses of BMS-188667 Given as a Single Intravenous Infusion to Patients With Psoriasis Vulgaris

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis Patients

Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis

Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects

Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Randomized Study of PH-10 for Psoriasis

Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris

A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118

Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque Psoriasis

Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice

Other Conditions in Los Angeles